NEXI - NexImmune Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-13.08M

Cash

22.32M

Avg Qtr Burn

-11.75M

Short % of Float

0.94%

Insider Ownership

28.23%

Institutional Own.

24.21%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NEXI-002 Details Multiple myeloma, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NEXI-001 Details Myelodysplastic syndrome, Acute myeloid leukemia, Cancer	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.